Newron Pharmaceuticals SpA (NP5.DE) - Stock Prices, Stock Peers & Analysis

Home
NP5.DE

Company Name	Newron Pharmaceuticals SpA
Symbol	NP5.DE
Currency	EUR
Price	8.71
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	173,842,019
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	6.9 - 11.9
Industry	Pharmaceuticals, Biotechnology & Life Sciences
Sector	Healthcare
CEO	Prof. Stefan Weber
Website	https://www.newron.com/

An error occurred while fetching data.

About Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS)